Related Experiment Video
Updated: Jun 3, 2026
05:31
Disruption of the Mouse Blood-Brain Barrier by Small Extracellular Vesicles from Hypoxic Human Placentas
Published on: January 26, 2024
Maternal serum inhibin-A for predicting preeclampsia
Mohamed Nabih El-Gharib1, Ma Morad
1Department of Obstetrics & Gynecology and Clinical Pathology, Faculty of Medicine, Tanta University, Tanta, Egypt. mohgharib@hotmail.com
Summary
Maternal serum inhibin-A levels in early pregnancy can predict preeclampsia. Higher inhibin-A concentrations were observed in women who later developed preeclampsia, suggesting its utility as a predictive biomarker.
Area of Science:
- Obstetrics and Gynecology
- Reproductive Endocrinology
- Maternal-Fetal Medicine
Background:
- Preeclampsia is a significant cause of maternal and fetal morbidity.
- Early prediction of preeclampsia is crucial for timely intervention and improved outcomes.
Purpose of the Study:
- To assess the efficacy of maternal serum inhibin-A levels in the late first trimester for predicting preeclampsia.
- To investigate inhibin-A as a potential biomarker for early preeclampsia detection.
Main Methods:
- A prospective study involving 327 pregnant women.
- Collection of maternal serum samples in the late first trimester for inhibin-A measurement.
- Comparison of inhibin-A levels between women who developed preeclampsia and healthy controls.
Main Results:
- Maternal serum inhibin-A concentrations were significantly elevated in women who subsequently developed preeclampsia.
- This elevation was observed in the late first trimester, prior to clinical manifestation of preeclampsia.
Conclusions:
- Late first-trimester maternal serum inhibin-A measurement is a valuable tool for predicting preeclampsia.
- Inhibin-A shows promise as an early predictive biomarker for preeclampsia.